Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEFL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,265
Award facts
- Contract value 100% obligated
- $48,265.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $48,265.40 with a firm fixed-price structure, was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The award carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will deliver pharmaceutical products and medical consumables to support Department of Defense healthcare operations, with an ultimate completion date of February 3, 2026.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical sourcing for military medical facilities. The PPV-G GEN V contract, valued at $499,999,999 and effective through December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system, positioning it as a critical supplier within the Department of Defense's healthcare supply chain.
Quick answers
Who was awarded contract SPE2DU26FEEFL?
SPE2DU26FEEFL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DU26FEEFL worth?
The government has obligated $48,265 on SPE2DU26FEEFL.
Is contract SPE2DU26FEEFL an order under another contract?
Yes. SPE2DU26FEEFL is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEFL competed?
The extent of competition for SPE2DU26FEEFL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award